Franklin Resources Inc. Acquires 77,027 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Franklin Resources Inc. lifted its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 273.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 105,228 shares of the company's stock after purchasing an additional 77,027 shares during the quarter. Franklin Resources Inc. owned about 0.11% of Acadia Healthcare worth $6,673,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. GAMMA Investing LLC increased its holdings in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after buying an additional 241 shares during the last quarter. Commonwealth Equity Services LLC boosted its position in shares of Acadia Healthcare by 3.5% in the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company's stock valued at $513,000 after acquiring an additional 257 shares during the period. Atria Investments Inc grew its stake in shares of Acadia Healthcare by 4.7% in the third quarter. Atria Investments Inc now owns 6,844 shares of the company's stock valued at $434,000 after acquiring an additional 308 shares in the last quarter. KBC Group NV raised its stake in Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company's stock worth $170,000 after purchasing an additional 338 shares in the last quarter. Finally, Tidal Investments LLC boosted its holdings in Acadia Healthcare by 7.9% in the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company's stock valued at $296,000 after purchasing an additional 340 shares during the period.

Acadia Healthcare Stock Performance

Shares of NASDAQ ACHC traded down $0.40 during trading on Monday, reaching $37.50. 2,655,637 shares of the stock traded hands, compared to its average volume of 1,069,152. The company has a 50-day moving average of $43.80 and a 200-day moving average of $60.73. Acadia Healthcare Company, Inc. has a 52-week low of $36.50 and a 52-week high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market capitalization of $3.48 billion, a P/E ratio of 12.30, a price-to-earnings-growth ratio of 1.77 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million for the quarter, compared to analysts' expectations of $819.42 million. During the same period in the prior year, the business posted $0.91 earnings per share. The company's revenue was up 8.7% on a year-over-year basis. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Royal Bank of Canada reduced their price objective on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a research note on Monday, November 18th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. Barclays dropped their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a research note on Friday, November 22nd. StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and increased their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $75.44.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.